Cargando…

CGRP measurements in human plasma – a methodological study

BACKGROUND: Calcitonin gene-related peptide plasma levels have frequently been determined as a biomarker for primary headaches. However, published data is often inconsistent resulting from different methods that are not precisely described in most studies. METHODS: We applied a well-proven enzyme-li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Messlinger, Karl, Vogler, Birgit, Kuhn, Annette, Sertel-Nakajima, Julika, Frank, Florian, Broessner, Gregor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592105/ https://www.ncbi.nlm.nih.gov/pubmed/34266288 http://dx.doi.org/10.1177/03331024211024161

Ejemplares similares

Short Report of Longitudinal CGRP-Measurements in Migraineurs During a Hypoxic Challenge
por: Frank, Florian, et al.
Publicado: (2022)

The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats
por: Vogler, Birgit, et al.
Publicado: (2023)

The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow
por: Dux, Mária, et al.
Publicado: (2022)

CGRP outflow into jugular blood and cerebrospinal fluid and permeance for CGRP of rat dura mater
por: Risch, Miriam, et al.
Publicado: (2021)

Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels
por: Kleeberg-Hartmann, Johanna, et al.
Publicado: (2021)

Semi-Automated Recording of Facial Sensitivity in Rat Demonstrates Antinociceptive Effects of the Anti-CGRP Antibody Fremanezumab
por: Benedicter, Nicola, et al.
Publicado: (2023)

The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
por: Messlinger, Karl
Publicado: (2018)

The chicken and egg problem: CGRP release due to trigeminal activation or vice versa?
por: Messlinger, Karl
Publicado: (2021)

Role Of Cgrp In Sensitization Of Dura Mater
por: Messlinger, K.
Publicado: (2001)

CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis
por: Frank, Florian, et al.
Publicado: (2021)

Photoactivation of olfactory sensory neurons does not affect action potential conduction in individual trigeminal sensory axons innervating the rodent nasal cavity
por: Maurer, Margot, et al.
Publicado: (2019)

Monoclonal antibodies against CGRP (R): non-responders and switchers: real world data from an austrian case series
por: Kaltseis, Katharina, et al.
Publicado: (2023)

Release of CGRP from mouse brainstem slices indicates central inhibitory effect of triptans and kynurenate
por: Kageneck, Charlotte, et al.
Publicado: (2014)

Migraine and aura triggered by normobaric hypoxia
por: Frank, Florian, et al.
Publicado: (2020)

Case report: Monoclonal CGRP-antibody treatment in a migraine patient with a mutation in the mitochondrial single-strand binding protein (SSBP1)
por: Kaltseis, Katharina, et al.
Publicado: (2022)

Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review
por: Kaltseis, Katharina, et al.
Publicado: (2022)

Excitatory Effects of Calcitonin Gene-Related Peptide (CGRP) on Superficial Sp5C Neurons in Mouse Medullary Slices
por: Zheng, Fang, et al.
Publicado: (2021)

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study
por: Straube, Andreas, et al.
Publicado: (2023)

CGRP and CGRP receptors in human and rhesus monkey cerebellum
por: Eftekhari, S, et al.
Publicado: (2013)

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment
por: Seiler, Kristin, et al.
Publicado: (2013)

CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
por: Kamm, Katharina
Publicado: (2022)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

Understanding side-effects of anti-CGRP and anti-CGRP receptor antibodies
por: Haanes, Kristian Agmund, et al.
Publicado: (2020)

Lipidated Calcitonin Gene-Related Peptide (CGRP) Peptide Antagonists Retain CGRP Receptor Activity and Attenuate CGRP Action In Vivo
por: Jamaluddin, Aqfan, et al.
Publicado: (2022)

Serotonin and CGRP in Migraine
por: Aggarwal, Milan, et al.
Publicado: (2012)

New CGRP Antagonists
por: Doods, H. N., et al.
Publicado: (2001)

Cgrp Characterization And Classification
por: Marshall, Ian
Publicado: (2001)

CGRP in Primary Headaches
por: Edvinsson, Lars
Publicado: (2001)

Hypoxia-related mechanisms inducing acute mountain sickness and migraine
por: Frank, Florian, et al.
Publicado: (2022)

Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system
por: Eftekhari, S, et al.
Publicado: (2013)

The Role of Cgrp-Receptor Component Protein (Rcp) in Cgrp-Mediated Signal Transduction
por: Prado, M. A., et al.
Publicado: (2001)

The vascular role of CGRP: a systematic review of human studies
por: Al-Karagholi, Mohammad Al-Mahdi, et al.
Publicado: (2023)

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
por: Berman, Gary, et al.
Publicado: (2020)

Methodological considerations on real-world evidence studies of monoclonal antibodies against the CGRP-pathway for migraine: a systematic review
por: Vandenbussche, Nicolas, et al.
Publicado: (2023)

CGRP release in an experimental human trigeminal pain model
por: Frese, Achim, et al.
Publicado: (2021)

Characterization of transit rates in the large intestine of mice following treatment with a CGRP antibody, CGRP receptor antibody, and small molecule CGRP receptor antagonists
por: Johnson, Kirk W., et al.
Publicado: (2022)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

CGRP and the Trigeminal System in Migraine
por: Iyengar, Smriti, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eiu60rhsuavtkn9hpbjdq1o8j7